Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-01 Purchase |
2022-09-01 4:28 pm |
Adagio Therapeutics Inc. | ADGI | Hering David Chief Executive Officer |
8,000 | $4.52 | $36,160 | 8,000 (Direct) |
View |
| 2022-08-17 Purchase |
2022-08-19 4:57 pm |
Adagio Therapeutics Inc. | ADGI | Elia Marc M28 Capital Management LP See Footnote 5 |
2,850,000 | $4.2788 | $12,194,680 | 9,248,250 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-23 Option Award |
2023-05-25 6:46 pm |
N/A 2033-05-22 |
Invivyd Inc. | IVVD | Heyman Tomas J. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 6:43 pm |
N/A 2033-05-22 |
Invivyd Inc. | IVVD | WYZGA MICHAEL S Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 6:43 pm |
N/A 2033-05-22 |
Invivyd Inc. | IVVD | Lindenboom Christine Director |
29,589 | $0 | 29,589 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 6:42 pm |
N/A 2033-05-22 |
Invivyd Inc. | IVVD | MEANWELL CLIVE Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 6:38 pm |
N/A 2033-05-22 |
Invivyd Inc. | IVVD | Berry Tamsin Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 6:37 pm |
N/A 2033-05-22 |
Invivyd Inc. | IVVD | Elia Marc M28 Capital Management LP See Remarks |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-04-11 Option Award |
2023-04-12 4:48 pm |
N/A 2033-04-10 |
Invivyd Inc. | IVVD | Allen Robert D. III Chief Scientific Officer |
600,000 | $0 | 600,000 (Direct) |
View |
| 2023-03-27 Option Award |
2023-03-28 4:57 pm |
N/A 2033-03-26 |
Invivyd Inc. | IVVD | Price Stacy Chief Tech. and Manuf. Officer |
475,000 | $0 | 475,000 (Direct) |
View |
| 2022-12-14 Option Award |
2022-12-16 5:20 pm |
N/A 2032-12-13 |
Invivyd Inc. | IVVD | Dabora Rebecca Chief Tech and Manuf Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-12-14 Option Award |
2022-12-16 5:16 pm |
N/A 2032-12-13 |
Invivyd Inc. | IVVD | Andersen Jill Chief Legal Officer, Secretary |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-12-14 Option Award |
2022-12-16 5:14 pm |
N/A 2032-12-13 |
Invivyd Inc. | IVVD | Schmidt Peter Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-16 5:11 pm |
N/A 2032-12-15 |
Invivyd Inc. | IVVD | Gowler Jeremy COO & CCO |
625,000 | $0 | 625,000 (Direct) |
View |
| 2022-12-14 Option Award |
2022-12-16 5:09 pm |
N/A 2032-12-13 |
Invivyd Inc. | IVVD | Hering David Chief Executive Officer |
1,600,000 | $0 | 1,600,000 (Direct) |
View |
| 2022-12-06 Option Award |
2022-12-06 5:55 pm |
N/A 2032-12-05 |
Invivyd Inc. | IVVD | Schmidt Peter Chief Medical Officer |
300,000 | $0 | 300,000 (Direct) |
View |
Ownership |
2022-12-06 5:52 pm |
N/A N/A |
Invivyd Inc. | IVVD | Schmidt Peter Chief Medical Officer |
0 | $0 | 193,671 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-04 4:06 pm |
N/A 2032-11-02 |
Invivyd Inc. | IVVD | Andersen Jill Chief Legal Officer, Secretary |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-10-20 Option Award |
2022-10-24 4:52 pm |
N/A 2032-10-19 |
Invivyd Inc. | IVVD | Lindenboom Christine Director |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 4:05 pm |
N/A 2032-07-04 |
Adagio Therapeutics Inc. | ADGI | Hering David Chief Executive Officer |
2,000,000 | $0 | 2,000,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:01 pm |
N/A 2032-06-21 |
Adagio Therapeutics Inc. | ADGI | MEANWELL CLIVE Director 10% Owner |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:44 pm |
N/A 2032-06-21 |
Adagio Therapeutics Inc. | ADGI | Berry Tamsin Director |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:40 pm |
N/A 2032-06-21 |
Adagio Therapeutics Inc. | ADGI | Elia Marc M28 Capital Management LP See Remarks |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:36 pm |
N/A 2032-06-21 |
Adagio Therapeutics Inc. | ADGI | Mayer Howard Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:35 pm |
N/A 2032-06-21 |
Adagio Therapeutics Inc. | ADGI | WYZGA MICHAEL S Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:32 pm |
N/A 2032-06-21 |
Adagio Therapeutics Inc. | ADGI | Miller Redonda Director |
44,178 | $0 | 44,178 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:31 pm |
N/A 2032-06-21 |
Adagio Therapeutics Inc. | ADGI | Heyman Tomas J. Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:28 pm |
N/A 2032-06-21 |
Adagio Therapeutics Inc. | ADGI | MCGUIRE TERRANCE Director |
75,000 | $0 | 75,000 (Direct) |
View |
Ownership(A) |
2022-04-06 5:02 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Cox Christopher T Population Health Equity Partners VII L.P. Population Health Equity Partners III GP LLC Population Health Equity Partners III L.P. Population Health Equity Partners VII GP LLC See Explanation of Responses |
0 | $0 | 679,822 (Indirect) |
View |
Ownership |
2022-04-01 4:15 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Elia Marc M28 Capital Management LP SEE REMARKS |
0 | $0 | 6,398,250 (Indirect) |
View |
| 2022-03-03 Other |
2022-04-01 4:08 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Adimab LLC See Remarks 10% Owner |
1,158,089 | $0 | 27,845,995 (Direct) |
View |
Ownership |
2022-03-30 9:57 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | MEANWELL CLIVE See Explanation of Responses. |
0 | $0 | 1,201,680 (Indirect) |
View |
Ownership |
2022-03-30 9:52 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Cox Christopher T See Explanation of Responses |
0 | $0 | 679,822 (Indirect) |
View |